Skip to main content
World Congress on Medical Oncology
Olympic Paris 2024
Test 4
Test 1
Test 2
Test 5
Test 3
Test clone mv
Olympic Paris 2024
Olympic Paris 2024 - VIP - Boss Ticket
Olympic Paris 2024
Finance Code Test
Concrete Institute of Australia’s Biennial National Conference 2025
Concrete Institute of Australia’s Biennial National Conference 2025
Test Goldenowl Conference
Virtual Event 01
Paris Olypmpic Clone 12.09 webinar
7th World Congress of Nanoentomology
NDS NAB Transact testing
JC test 01
Pre-Release 3 Oct
DEX (Digital Employee Experience) conference 2024
test derek
TimeZone Test
TimeZone Test
Talent Events
Event Demo
Olympic Paris 2024 x
original event name for cloning testing
Olympic Paris 2024
Default payment method test
evexus Event - 509
Default payment method test2
Test Worker
Test Worker
charlie test
Arinex 1
NET24 Ho Chi Minh City Workshop 2024
Telefilm 2024 - International Exhibition of Film and Television Technology in Vietnam
Olympic Paris 2024
charlie test 2711
charlie test 2711 cloned
CICM SecurePay testing
The AI Submit 2024
Test webinar 04.12 - - - -
Taylor Swift Clone 04
Taylor Swift Clone 02
Taylor Swift
Taylor Swift Clone
Taylor Swift Clone 01
Import Test
The Trading Summit 2024 (HCM - Vietnam)
Electric Dreams: A Synthwave Extravaganza
Taylor Swift 16
Taylor Swift 12
Taylor Swift 14
Taylor Swift 15
Taylor Swift 17
Taylor Swift 20
Coin Based Hackathon 2024
Rose 01
Import Ticket
Vu Cat Tuong
STEM 1
Kids STEM
CLONE Innovate 2025: A Future Forward Summit
Innovate 2025: A Future Forward Summit
Petals & Sunshine Festival
webinar 05/02
Science
evexus Event - 273
evexus Event - 275
Association webinar 5.2
evexus Event - 274
Aurora Nights 2025 - Webinar
Seoul AI Seminar
Webinar Event - Lily AI - 20/02
evexus Event - 287
Taylor Swift 11
Swifties Only Social Contact
cloned event for Bree QA
evexus Event - 288
evexus Event - 289
Bree QA event
Tim's event
Ralph's event
Tim cloned enable all
Ralph clone event the last one
Hawaii AI Seminar
evexus Event - 293
Tokyo Seminar
Indiana AI Seminar
Registration ticket 2025
TechNova Summit
Event - 28 - 03 - 2025
TechNova Summit [2]
TechNova Summit [3]
Tech v1
Event 28/03/2025
Job Affairs
Fan Job
Webinar Event - Lily AI - 04/03
Event Registration
Association webinar 20.2
Fan's stock query
Registration
Aurora Nights 2025
Ralph test email
Taylor Swift 13
The Core 2025
Rose
The Thirdweb submit
Stress Test Conference 2026
World Congress of Medical Oncology
Alan'event
The AI Seoul Submit 2026
The Core 2026
Times are shown in your local time zone GMT
Outcomes after robotic TAMIS (R-TAMIS) – lessons learnt from the first 10
Verbal Presentation

Verbal Presentation

7:48 am

03 May 2026

Meeting Room M6

COLORECTAL SURGERY - FREE PAPERS

Talk Description

Institution: Nepean Hospital - NSW, Australia

Purpose The use of robotic platforms for transanal resection (R-TAMIS) of rectal polyps and early malignancies is an increasingly utilised alternative to the conventional laparoscopic approach. Our robotic group wished to analyse surgical and oncological outcomes for our first ten R-TAMIS cases using the Da Vinci platform. Methods Data on consecutive R-TAMIS procedures over a 24-month period were prospectively collected and analysed. Post-operative rooms and clinic follow-up letters were also analysed to identify long-term complications. Results 10 patients (1:1 M/F), mean age 63.5 (51- 74) and mean BMI of 32.4 (22.8 – 44.5) underwent R-TAMIS using the Da Vinci Xi device. All cases were performed using the GelPOINT Path Platform. Two R-TAMIS were successfully performed by an ANZTBCRS fellow, utilising a dual-console system. Mean console time was 141 minutes (28 - 263). Resected lesions were a mean distance of 8 cm (6 -13) from the anal verge, and a mean of 51.7cm (15 – 95) in size. Five patients were demonstrated to have at least T1 adenocarcinoma, with the remainder having dysplastic lesions. Two patients failed to have their procedures completed with R-TAMIS, due to inaccurate pre-operative MRI staging, and two underwent subsequent successful completion laparoscopic low-anterior resection (LAR). One patient was found to have a dysplastic lesion only and avoided LAR after being diagnosed with invasive malignancy on preoperative biopsy. Two patients had reported complications (urinary retention and temporary faecal incontinence), and two had delayed discharges due to mobility issues. Conclusion Whilst R-TAMIS appears to be a viable and safe alternative to laparoscopic TAMIS and more invasive surgery for early rectal tumours, successful outcomes depend heavily on accurate pre-operative staging and ideally MDT discussion. It appears that R-TAMIS can also be taught safely to training fellows using appropriate teaching platforms.
Speakers
Contributors
Authors

Dr Sarah Johnston - , Dr Ewan Macdermid - , Dr Sinan Albayati - , Dr Bushra Othman - , Dr Walid Barto -

Other Suggested Talks
Privacy Statement Header

By confirming your acceptance below, you agree to our Privacy Policy